 | • レポートコード：20QY06-08277 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、百日咳ワクチンのグローバル市場について種類別（全細胞ワクチン、無細胞ワクチン）、用途別（子供、大人）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・百日咳ワクチン市場の概要 ・世界の主要地域別百日咳ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の百日咳ワクチン市場規模2015-2026：種類別（全細胞ワクチン、無細胞ワクチン） ・世界の百日咳ワクチン市場規模2015-2026：用途別（子供、大人） ・百日咳ワクチンの北米市場規模2015-2020 ・百日咳ワクチンのヨーロッパ市場規模2015-2020 ・百日咳ワクチンの中国市場規模2015-2020 ・百日咳ワクチンの日本市場規模2015-2020 ・百日咳ワクチンの東南アジア市場規模2015-2020 ・百日咳ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、Astellas Pharma、Minhai Biotechnology、Wuhan Institute of Biological Products、Changchun Changsheng Life Sciences） ・百日咳ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・百日咳ワクチンの市場動向・機会・課題 ・調査の結論 |
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform.
The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.
Market Analysis and Insights: Global Pertussis Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pertussis Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pertussis Vaccine industry.
Based on our recent survey, we have several different scenarios about the Pertussis Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 7136.1 million in 2019. The market size of Pertussis Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Pertussis Vaccine Scope and Market Size
The global Pertussis Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pertussis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pertussis Vaccine market is segmented into
Whole-cell vaccines
Acellular vaccines
Segment by Application, the Pertussis Vaccine market is segmented into
Children
Adults
The Pertussis Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pertussis Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pertussis Vaccine Market Share Analysis
Pertussis Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pertussis Vaccine business, the date to enter into the Pertussis Vaccine market, Pertussis Vaccine product introduction, recent developments, etc.
The major vendors covered:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
…
1 Pertussis Vaccine Market Overview
1.1 Pertussis Vaccine Product Scope
1.2 Pertussis Vaccine Segment by Type
1.2.1 Global Pertussis Vaccine Sales by Type (2020-2026)
1.2.2 Whole-cell vaccines
1.2.3 Acellular vaccines
1.3 Pertussis Vaccine Segment by Application
1.3.1 Global Pertussis Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Children
1.3.3 Adults
1.4 Pertussis Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pertussis Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Pertussis Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Pertussis Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Pertussis Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Pertussis Vaccine Industry
1.5.1.1 Pertussis Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Pertussis Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Pertussis Vaccine Players to Combat Covid-19 Impact
2 Pertussis Vaccine Estimate and Forecast by Region
2.1 Global Pertussis Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pertussis Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pertussis Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Pertussis Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Pertussis Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pertussis Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pertussis Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pertussis Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Pertussis Vaccine Estimates and Projections (2015-2026)
2.4.3 China Pertussis Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Pertussis Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pertussis Vaccine Estimates and Projections (2015-2026)
2.4.6 India Pertussis Vaccine Estimates and Projections (2015-2026)
3 Global Pertussis Vaccine Competition Landscape by Players
3.1 Global Top Pertussis Vaccine Players by Sales (2015-2020)
3.2 Global Top Pertussis Vaccine Players by Revenue (2015-2020)
3.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertussis Vaccine as of 2019)
3.4 Global Pertussis Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Pertussis Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pertussis Vaccine Players (Opinion Leaders)
4 Global Pertussis Vaccine Market Size by Type
4.1 Global Pertussis Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Pertussis Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Pertussis Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Pertussis Vaccine Price by Type (2014-2020)
4.2 Global Pertussis Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pertussis Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Pertussis Vaccine Price Forecast by Type (2021-2026)
5 Global Pertussis Vaccine Market Size by Application
5.1 Global Pertussis Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Pertussis Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Pertussis Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Pertussis Vaccine Price by Application (2015-2020)
5.2 Global Pertussis Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pertussis Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pertussis Vaccine Price Forecast by Application (2021-2026)
3 North America Pertussis Vaccine Market Facts & Figures
3.2 North America Pertussis Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Pertussis Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Pertussis Vaccine Sales Market Share by Application (2015-2020)
4 Europe Pertussis Vaccine Market Facts & Figures
4.2 Europe Pertussis Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Pertussis Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Pertussis Vaccine Sales Market Share by Application (2015-2020)
5 China Pertussis Vaccine Market Facts & Figures
5.2 China Pertussis Vaccine Sales Market Share by Company (2015-2020)
5.3 China Pertussis Vaccine Sales Market Share by Type (2015-2020)
5.4 China Pertussis Vaccine Sales Market Share by Application (2015-2020)
6 Japan Pertussis Vaccine Market Facts & Figures
6.2 Japan Pertussis Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Pertussis Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Pertussis Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Pertussis Vaccine Market Facts & Figures
7.2 Southeast Asia Pertussis Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pertussis Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pertussis Vaccine Sales Market Share by Application (2015-2020)
8 India Pertussis Vaccine Market Facts & Figures
8.2 India Pertussis Vaccine Sales Market Share by Company (2015-2020)
8.3 India Pertussis Vaccine Sales Market Share by Type (2015-2020)
8.4 India Pertussis Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pertussis Vaccine Business
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Pertussis Vaccine Corporation Information
12.1.2 Sanofi Pasteur Pertussis Vaccine Business Overview and Total Revenue
12.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Pasteur Pertussis Vaccine Products Offered
12.1.5 Sanofi Pasteur Recent Development
12.2 GSK
12.2.1 GSK Pertussis Vaccine Corporation Information
12.2.2 GSK Pertussis Vaccine Business Overview and Total Revenue
12.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Pertussis Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Mitsubishi Tanabe Pharma
12.3.1 Mitsubishi Tanabe Pharma Pertussis Vaccine Corporation Information
12.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Business Overview and Total Revenue
12.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
12.3.5 Mitsubishi Tanabe Pharma Recent Development
12.4 Astellas Pharma
12.4.1 Astellas Pharma Pertussis Vaccine Corporation Information
12.4.2 Astellas Pharma Pertussis Vaccine Business Overview and Total Revenue
12.4.3 Astellas Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Astellas Pharma Pertussis Vaccine Products Offered
12.4.5 Astellas Pharma Recent Development
12.5 Minhai Biotechnology
12.5.1 Minhai Biotechnology Pertussis Vaccine Corporation Information
12.5.2 Minhai Biotechnology Pertussis Vaccine Business Overview and Total Revenue
12.5.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Minhai Biotechnology Pertussis Vaccine Products Offered
12.5.5 Minhai Biotechnology Recent Development
12.6 Wuhan Institute of Biological Products
12.6.1 Wuhan Institute of Biological Products Pertussis Vaccine Corporation Information
12.6.2 Wuhan Institute of Biological Products Pertussis Vaccine Business Overview and Total Revenue
12.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
12.6.5 Wuhan Institute of Biological Products Recent Development
12.7 Changchun Changsheng Life Sciences
12.7.1 Changchun Changsheng Life Sciences Pertussis Vaccine Corporation Information
12.7.2 Changchun Changsheng Life Sciences Pertussis Vaccine Business Overview and Total Revenue
12.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Changchun Changsheng Life Sciences Pertussis Vaccine Products Offered
12.7.5 Changchun Changsheng Life Sciences Recent Development
…
13 Pertussis Vaccine Manufacturing Cost Analysis
13.1 Pertussis Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pertussis Vaccine
13.4 Pertussis Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pertussis Vaccine Distributors List
14.3 Pertussis Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pertussis Vaccine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Pertussis Vaccine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Pertussis Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Pertussis Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Pertussis Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Pertussis Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Pertussis Vaccine Sales (K Doses) by Region (2015-2020)
Table 10. Global Pertussis Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Pertussis Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Pertussis Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Pertussis Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Pertussis Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Pertussis Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Pertussis Vaccine (K Doses) of Key Companies (2015-2020)
Table 18. Global Pertussis Vaccine Sales Share by Company (2015-2020)
Table 19. Global Pertussis Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Pertussis Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertussis Vaccine as of 2019)
Table 22. Global Pertussis Vaccine Average Price (USD/Doses) of Key Company (2015-2020)
Table 23. Manufacturers Pertussis Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Pertussis Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Pertussis Vaccine Players
Table 27. Global Pertussis Vaccine Sales (K Doses) by Type (2015-2020)
Table 28. Global Pertussis Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Pertussis Vaccine Price (K Doses) by Type (2015-2020)
Table 31. Global Pertussis Vaccine Sales Share by Type (2021-2026)
Table 32. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Pertussis Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Pertussis Vaccine Price (K Doses) by Type (2021-2026)
Table 35. Global Pertussis Vaccine Sales (K Doses) by Application (2015-2020)
Table 36. Global Pertussis Vaccine Sales Share by Application (2015-2020)
Table 37. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Pertussis Vaccine Price (K Doses) by Application (2015-2020)
Table 39. Global Pertussis Vaccine Sales (K Doses) by Application (2021-2026)
Table 40. Global Pertussis Vaccine Sales Share by Application (2021-2026)
Table 41. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Pertussis Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Pertussis Vaccine Price (K Doses) by Application (2021-2026)
Table 44. United States Pertussis Vaccine Sales (K Doses) by Company (2015-2020)
Table 45. United States Pertussis Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Pertussis Vaccine Sales (K Doses) by Type (2015-2020)
Table 47. United States Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Pertussis Vaccine Sales (K Doses) by Application (2015-2020)
Table 49. United States Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Pertussis Vaccine Sales (K Doses) by Company (2015-2020)
Table 51. Europe Pertussis Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Pertussis Vaccine Sales (K Doses) by Type (2015-2020)
Table 53. Europe Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Pertussis Vaccine Sales (K Doses) by Application (2015-2020)
Table 55. Europe Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Pertussis Vaccine Sales (K Doses) by Company (2015-2020)
Table 57. China Pertussis Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Pertussis Vaccine Sales (K Doses) by Type (2015-2020)
Table 59. China Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Pertussis Vaccine Sales (K Doses) by Application (2015-2020)
Table 61. China Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Pertussis Vaccine Sales (K Doses) by Company (2015-2020)
Table 63. Japan Pertussis Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Pertussis Vaccine Sales (K Doses) by Type (2015-2020)
Table 65. Japan Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Pertussis Vaccine Sales (K Doses) by Application (2015-2020)
Table 67. Japan Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Pertussis Vaccine Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Pertussis Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Pertussis Vaccine Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Pertussis Vaccine Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Pertussis Vaccine Sales (K Doses) by Company (2015-2020)
Table 75. India Pertussis Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Pertussis Vaccine Sales (K Doses) by Type (2015-2020)
Table 77. India Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Pertussis Vaccine Sales (K Doses) by Application (2015-2020)
Table 79. India Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 80. Sanofi Pasteur Corporation Information
Table 81. Sanofi Pasteur Description and Business Overview
Table 82. Sanofi Pasteur Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 83. Sanofi Pasteur Pertussis Vaccine Product
Table 84. Sanofi Pasteur Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 88. GSK Pertussis Vaccine Product
Table 89. GSK Recent Development
Table 90. Mitsubishi Tanabe Pharma Corporation Information
Table 91. Mitsubishi Tanabe Pharma Description and Business Overview
Table 92. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 93. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
Table 94. Mitsubishi Tanabe Pharma Recent Development
Table 95. Astellas Pharma Corporation Information
Table 96. Astellas Pharma Description and Business Overview
Table 97. Astellas Pharma Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 98. Astellas Pharma Pertussis Vaccine Product
Table 99. Astellas Pharma Recent Development
Table 100. Minhai Biotechnology Corporation Information
Table 101. Minhai Biotechnology Description and Business Overview
Table 102. Minhai Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 103. Minhai Biotechnology Pertussis Vaccine Product
Table 104. Minhai Biotechnology Recent Development
Table 105. Wuhan Institute of Biological Products Corporation Information
Table 106. Wuhan Institute of Biological Products Description and Business Overview
Table 107. Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 108. Wuhan Institute of Biological Products Pertussis Vaccine Product
Table 109. Wuhan Institute of Biological Products Recent Development
Table . Changchun Changsheng Life Sciences Corporation Information
Table . Changchun Changsheng Life Sciences Description and Business Overview
Table . Changchun Changsheng Life Sciences Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table . Changchun Changsheng Life Sciences Pertussis Vaccine Product
Table . Changchun Changsheng Life Sciences Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Pertussis Vaccine Distributors List
Table 118. Pertussis Vaccine Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pertussis Vaccine Market Share by Application in 2020 & 2026
Figure 6. Children Examples
Figure 7. Adults Examples
Figure 8. Global Pertussis Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Pertussis Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Pertussis Vaccine Price Trends Growth Rate (2015-2026) (USD/Doses)
Figure 11. Global Pertussis Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Pertussis Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Pertussis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Pertussis Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Pertussis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Pertussis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Pertussis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Pertussis Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Pertussis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Pertussis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Pertussis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pertussis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Pertussis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Pertussis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Pertussis Vaccine Players Market Share by Revenue in Pertussis Vaccine 2015 & 2019
Figure 26. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Pertussis Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Pertussis Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Pertussis Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Pertussis Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Pertussis Vaccine Sales Market Share by Type in 2019
Figure 32. United States Pertussis Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Pertussis Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Pertussis Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Pertussis Vaccine Sales Market Share by Application in 2019
Figure 36. China Pertussis Vaccine Sales Market Share by Company in 2019
Figure 37. China Pertussis Vaccine Sales Market Share by Type in 2019
Figure 38. China Pertussis Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Pertussis Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Pertussis Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Pertussis Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Pertussis Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Pertussis Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Pertussis Vaccine Sales Market Share by Application in 2019
Figure 45. India Pertussis Vaccine Sales Market Share by Company in 2019
Figure 46. India Pertussis Vaccine Sales Market Share by Type in 2019
Figure 47. India Pertussis Vaccine Sales Market Share by Application in 2019
Figure 48. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Minhai Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Wuhan Institute of Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Changchun Changsheng Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Pertussis Vaccine
Figure 57. Manufacturing Process Analysis of Pertussis Vaccine
Figure 58. Pertussis Vaccine Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
ジフテリア・百日咳・破傷風ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diphtheria, Pertussis, and Tetanus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 2999.7 million by 2025, from USD 2595 million in 2019.…- ジフテリア、破傷風、百日咳（DTaP）ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.…
- 全ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global All Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…
- インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
- ペット用ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Pet Vaccine Market The global Pet Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Pet Vaccine Scope and Market Size The global Pet Vaccine market is segmented …